to Assess the Eradication Rate of 14-day Bismuth/Amoxicillin/PCAB Triple Therapy for the Treatment of Helicobacter Pylori Infection

NCT07142798 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

200

Enrollment

OTHER

Sponsor class

Conditions

HELICOBACTER PYLORI INFECTIONS

Interventions

DRUG: Bismuth amoxilillin potassium

Sponsor

Kaohsiung Medical University

Collaborators

[object Object]